2022 20th International Conference on Emerging eLearning Technologies and Applications (ICETA) Emerging eLearning Technologies and Applications (ICETA), 2022 20th International Conference on. :300-305 Oct, 2022
2022 20th International Conference on Emerging eLearning Technologies and Applications (ICETA) Emerging eLearning Technologies and Applications (ICETA), 2022 20th International Conference on. :466-471 Oct, 2022
2021 19th International Conference on Emerging eLearning Technologies and Applications (ICETA) Emerging eLearning Technologies and Applications (ICETA), 2021 19th International Conference on. :276-281 Nov, 2021
Siddiqi, Z A, Nowak, R J, Mozaffar, T, O'Brien, F, Yountz, M, Patti, F, Mazia, C G, Wilken, M, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D'Hont, A, Tilkin, P, de Siqueira Carvalho, A A, Brockhausen, I D, Feder, D, Ambrosio, D, César, P, Melo, A P, Ribeiro, R M, Rocha, R, Rosa, B B, Andersen, H, Vissing, J, Højgaard, J, Witting, N, Pedersen, J, Weiss, M & The REGAIN Study Group 2021, ' Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab : subgroup analysis of REGAIN and its extension study ', Muscle and Nerve, vol. 64, no. 6, pp. 662-669 . https://doi.org/10.1002/mus.27422 Muscle & nerve, 64(6), 662-669. John Wiley and Sons Inc.
Vissing, J, Jacob, S, Fujita, K P, O’Brien, F, Howard, J F, The REGAIN Study Group, Mazia, C G, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D’Hont, A, Tilkin, P, Alves de Siqueira Carvalho, A, Dias Brockhausen, I, Feder, D, Ambrosio, D, César, P, Melo, A P, Martins Ribeiro, R, Rocha, R, Rosa, B B, Veiga, T, da Silva, L A, Andersen, H, Harbo, T, Vinge, L, Krogh, S, Mogensen, A, Vissing, J, Højgaard, J, Witting, N, Autzen, A M O, Pedersen, J & Weiss, M 2020, ' ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab ', Journal of Neurology, vol. 267, pp. 1991-2001 . https://doi.org/10.1007/s00415-020-09770-y JOURNAL OF NEUROLOGY Journal of Neurology Journal of neurology, 267(7), 1991-2001. D. Steinkopff-Verlag